Skip to Content
주식/증권 📈 긍정적

BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock?

요약

Bristol Myers growth brands and pipeline progress are boosting momentum, but generic pressure on its legacy portfolio warrants caution.